JPS5369820A - Ubidecanolene inclusion compound - Google Patents

Ubidecanolene inclusion compound

Info

Publication number
JPS5369820A
JPS5369820A JP14410476A JP14410476A JPS5369820A JP S5369820 A JPS5369820 A JP S5369820A JP 14410476 A JP14410476 A JP 14410476A JP 14410476 A JP14410476 A JP 14410476A JP S5369820 A JPS5369820 A JP S5369820A
Authority
JP
Japan
Prior art keywords
ubidecanolene
inclusion compound
inclusion
compound
ubidecanolene inclusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14410476A
Other languages
Japanese (ja)
Other versions
JPS5852977B2 (en
Inventor
Kouhei Miyao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMU ESU SHII YUUGEN
Original Assignee
EMU ESU SHII YUUGEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EMU ESU SHII YUUGEN filed Critical EMU ESU SHII YUUGEN
Priority to JP51144104A priority Critical patent/JPS5852977B2/en
Publication of JPS5369820A publication Critical patent/JPS5369820A/en
Publication of JPS5852977B2 publication Critical patent/JPS5852977B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP51144104A 1976-12-01 1976-12-01 Ubidecanolene clathrate Expired JPS5852977B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP51144104A JPS5852977B2 (en) 1976-12-01 1976-12-01 Ubidecanolene clathrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51144104A JPS5852977B2 (en) 1976-12-01 1976-12-01 Ubidecanolene clathrate

Publications (2)

Publication Number Publication Date
JPS5369820A true JPS5369820A (en) 1978-06-21
JPS5852977B2 JPS5852977B2 (en) 1983-11-26

Family

ID=15354266

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51144104A Expired JPS5852977B2 (en) 1976-12-01 1976-12-01 Ubidecanolene clathrate

Country Status (1)

Country Link
JP (1) JPS5852977B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6089442A (en) * 1983-10-21 1985-05-20 M S C:Kk Ubidecarenone clathrate compound
WO2005111224A3 (en) * 2004-05-18 2006-06-08 Kemijski Inst Water-soluble coenzyme q10 in inclusion complex with beta-cyclodextrin, process of preparing, and use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6089442A (en) * 1983-10-21 1985-05-20 M S C:Kk Ubidecarenone clathrate compound
WO2005111224A3 (en) * 2004-05-18 2006-06-08 Kemijski Inst Water-soluble coenzyme q10 in inclusion complex with beta-cyclodextrin, process of preparing, and use thereof

Also Published As

Publication number Publication date
JPS5852977B2 (en) 1983-11-26

Similar Documents

Publication Publication Date Title
JPS5368786A (en) Heterocycltc compound
IL48824A0 (en) Thc-type compounds
JPS52151348A (en) Compound
JPS5363424A (en) Bitumious compound
JPS52125197A (en) Transshexahydroopyridooindole compound
JPS5395993A (en) Novel 88azapurinee88one compound
JPS5353618A (en) Nnsubstituted biscarbamoylsulfide compound
JPS55127390A (en) Aryltrifluoroethylamine compound
JPS5295689A (en) Betaalactummcontaining compound
JPS5337653A (en) 111deoxyy111oxaprostaglandin compound
JPS5359686A (en) Compound
JPS5325537A (en) Compound
JPS5293772A (en) Indolinospiropyran compound
JPS5716827A (en) Novel compound
JPS5323995A (en) Antiibacterial compound
JPS5473826A (en) New compound
CY1178A (en) 21-halogenopregnane compounds
JPS5321222A (en) Bissbenzoxazolyl compound
JPS52156899A (en) Compound
JPS536416A (en) 55fluorouracli inclusion compound
JPS5353692A (en) Antiiworm compound
JPS539793A (en) Novel cephlosporin compound
JPS55102588A (en) Tetraselenapentalene compound
JPS5325229A (en) Fiberrreinforced compound member
ZA772175B (en) Oxothia compounds